-
psnet.ahrq.gov/issue/application-human-factors-analysis-and-classification-system-methodology-cardiovascular
January 06, 2012 - Application of the human factors analysis and classification system methodology to the cardiovascular … Application of the human factors analysis and classification system methodology to the cardiovascular … Application of the human factors analysis and classification system methodology to the cardiovascular … January 6, 2012
Development and pilot evaluation of a preoperative briefing protocol for cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
June 02, 2025 - Severe Sepsis and Septic Shock
Term Definition
Severe sepsis Sepsis plus one of the following: cardiovascular … OR
• “Rule out sepsis” OR
• “Suspected sepsis”
Severe sepsis Sepsis plus one of the following: cardiovascular … syndrome OR two or more other organ dysfunctions.
2
Term Definition
Organ
dysfunctions
Cardiovascular … not applicable for newborn)
OR
ALT 2 times upper limit of normal for age
Septic Shock Sepsis and cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
October 01, 2009 - Layout 1
Background
Nearly 2,400 Americans die of
cardiovascular disease each day, an average
of one … Cardiovascular disease claims more lives
each year than cancer, chronic lower
respiratory diseases, accidents … Since
1900, cardiovascular disease has accounted
for more deaths than any other single cause
or group … The TRANSCEND (Telmisartan Randomized
AssessmeNt Study in ACE iNtolerant subjects with
cardiovascular … Composite of High • ACE inhibitor or ARB therapy is better than placebo in
cardiovascular mortality,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
January 01, 2011 - walking
time and distance; improved wound healing; decreased rates of amputation; decreased
rates of cardiovascular … Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke,
cardiovascular death) in … Is clopidogrel more effective than aspirin in reducing adverse cardiovascular events
in PAD?
3. … )
PAD is a prevalent disease associated with an increased risk of cardiovascular events.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
January 01, 2010 - response to clopidogrel in patients (1) with acute
coronary syndromes, (2) who have suffered other cardiovascular … PICO
Population(s): (1) Patients with acute coronary syndrome, (2) patients who have
suffered other cardiovascular … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease-
related morbidity and … treatment choice for
patients who require antiplatelet therapy for the prevention of major adverse
cardiovascular … )
While clopidogrel may decrease morbidity and mortality associated with several cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-nyc.pdf
November 01, 2017 - ensure that primary care practices have the evidence they need to help their patients adopt the
ABCS of cardiovascular … and 13 percent Asian).1 Heart disease is the primary cause of
death in the city, and prevalence of cardiovascular … Practice Facilitation in a Cluster
Randomized Stepped Wedge Design Trial to Improve
Adherence to Cardiovascular … Summit,
2016]
• Using Practice Facilitation in primary care settings to
reduce risk factors for cardiovascular … Conference, 2016]
• Using Practice Facilitation in primary care settings to
reduce risk factors for cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-6mon-post-intervention-sw.pdf
April 03, 2017 - Please identify how your practice uses clinical guidelines for cardiovascular
disease prevention (for … Reporting measurements of practice performance
on cardiovascular disease prevention measures
(such as … Setting goals and benchmarking rates of
performance quality on cardiovascular disease
prevention measures … Customizing the implementation of cardiovascular
disease prevention care changes to the practice £ £ … [Check all that apply]
¨ Aspirin use for patients with ASCVD (atherosclerotic cardiovascular disease
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/cholesterol-academic-detailing-guide.pdf
July 07, 2015 - coronary artery disease1,2
i16%
Reduction in
absolute risk of
death
i20%
Reduction in all
major cardiovascular … events
Manage cholesterol aggressively for patients at highest risk
of atherosclerotic cardiovascular … C-reactive protein and parental history improve global cardiovascular risk prediction: the
Reynolds … General cardiovascular risk profile for use in primary care: the Framingham Heart Study.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
November 02, 2023 - progress
Final Research Plan
Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular … Abbreviations: BP=blood pressure; CVD=cardiovascular … behavioral counseling interventions to promote healthy diet, physical activity, and/or weight loss improve cardiovascular … e.g., nutritional deficiencies, disordered eating, symptoms of anxiety, musculoskeletal injuries, or cardiovascular … Abbreviations: BMI=body mass index; CVD=cardiovascular disease; KQ=key question; USPSTF=U.S.
-
integrationacademy.ahrq.gov/sites/default/files/2020-07/Ischemic_Vascular_Disease_Blood_Pressure_Control.pdf
January 01, 2020 - Adjustment:
No
Classification:
National Quality Strategy Priorities:
Prevention and Treatment of Cardiovascular … System (PQRS)
Actual/Planned Use:
Care Setting:
Ambulatory Care: Clinician Office/Clinic
Condition:
Cardiovascular … , Cardiovascular: Ischemic Heart Disease, Coronary Artery Disease
Cross-Cutting Area:
Data Source:
-
www.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/virginia.html
March 01, 2021 - that primary care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular … experiences racial, ethnic, and economic disparities in access to care and effectiveness of care for cardiovascular … research (PCOR) findings (both clinical and organizational) into practice, with an initial focus on cardiovascular … :
Association Between Practice Ownership or Affiliation With Baseline Performance on Addressing Cardiovascular … Healthcare Report [NAPCRG, 2017]
Joy in practice as an enabling strategy for quality improvement in cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BXkaHRFGjwUCoyANeMSuTz
January 01, 2010 - ahrq12a_Summary_HBP.qxd
In the United States, hypertension is responsible
for 35% of all cardiovascular … Results
Key Question 1: Does Screening
for Hypertension Reduce
Cardiovascular Disease and
Mortality? … The absolute risk for cardiovascular
events, however, varies depending on the presence of
other cardiovascular … Blood pressure as a cardiovascular risk
factor: prevention and treatment. … How do we best
individualize treatment for patients based on their
cardiovascular risk profile?
-
meps.ahrq.gov/data_files/publications/st410/stat410.shtml
May 01, 2013 - Cardiovascular agents were purchased by 28.3 percent of the population and a little less than one-fourth … five therapeutic classes, followed by metabolic agents ($93), central nervous system agents ($65), and cardiovascular … Therapeutic class cardiovascular agents include calcium channel blockers and diuretics; central nervous … Classification Percentage
Metabolic agents 19.4
Central nervous system agents 13.4
Cardiovascular … Classification Percentage
Metabolic agents 23.3
Central nervous system agents 30.9
Cardiovascular
-
meps.ahrq.gov/data_files/publications/st153/stat153.pdf
December 01, 2006 - billion) in
y three-quarters of Medi-
eneficiaries age 65 and
with a prescribed drug
se had a cardiovascular … 74.5 percent) in
which was a higher per-
ge than any of the other
e therapeutic classes of
.
4, cardiovascular … (figure 1)
In 2004, annual expenses for cardiovascular agents represented a quarter (25.8 percent … expense, of the top five therapeutic classes for Medicare beneficiaries age 65 and
older in 2004, cardiovascular … 65 and older, 2004
16.7
10.4
8.1
6.8 5.6
0
10
20
30
Medicare population age 65 and older
Cardiovascular
-
meps.ahrq.gov/data_files/publications/st313/stat313.shtml
February 01, 2011 - expense among adults for prescription drugs were: metabolic agents, central nervous system agents, cardiovascular … which was more than three times the average expense of the therapeutic class with the lowest average (cardiovascular … The therapeutic class cardiovascular agents includes calcium channel blockers and diuretics; central … prescribed drug expenses
Metabolic agents 22.5
Central nervous system agents 15.1
Cardiovascular … prescribed drug expenses
Metabolic agents 33.8
Central nervous system agents 46.0
Cardiovascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF5BNLvASN5r9EnP3VTJPN
December 01, 2010 - Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease … Advice to reduce dietary salt
for prevention of cardiovascular disease. … Diet and
exercise are equally effective in reducing risk for cardiovascular disease. … Prevention of cardiovascular risk factor eleva-
tions in healthy premenopausal women. … CVD � cardiovascular disease; KQ � key question.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Data_Requirements_Statin_CVD_Patient_Facing.xlsx
January 01, 2024 - SNOMED-CT code) LOINC: 63895-7 (question) SNOMED-CT: 55561003 (qualifier)
Myocardial Infarction (MI)
(Cardiovascular … 2.16.840.1.113883.3.526.3.403
2.16.840.1.113883.3.464.1003.104.12.1001
Ischemic vascular disease
(Cardiovascular … 8 VSs
IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003
Coronary Artery Bypass Graft (CABG)
(Cardiovascular … of 2 VSs 2.16.840.1.113883.3.3157.2000.1
2.16.840.1.113883.3.3157.2000.2
Carotid Intervention
(Cardiovascular … 8 VSs
IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003
Coronary Artery Bypass Graft (CABG)
(Cardiovascular
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_Data_Requirements_Healthy_Diet_and_Physical_Activity.xlsx
January 01, 2024 - 2.16.840.1.113883.3.464.1003.195.12.1003 2.16.840.1.113762.1.4.1032.307
Myocardial Infarction (MI)
(Cardiovascular … 2.16.840.1.113883.3.526.3.403
2.16.840.1.113883.3.464.1003.104.12.1001
Ischemic vascular disease
(Cardiovascular … 8 VSs
IVD:Single VS 2.16.840.1.113883.3.464.1003.104.12.1003
Coronary Artery Bypass Graft (CABG)
(Cardiovascular … of 2 VSs 2.16.840.1.113883.3.3157.2000.1
2.16.840.1.113883.3.3157.2000.2
Carotid Intervention
(Cardiovascular … or false CVD = Union of 8 VSs Carotid Intervention: Single VS 2.16.840.1.113883.3.117.1.7.1.204
Cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/enhancing-care-heart-failure-patients.pdf
June 02, 2025 - Investigator,
Associate Director of the Cardiac Rehab
Program at Brigham and Women’s
Hospital, Division of Cardiovascular … Cardiology
Unit at Henry Ford Hospital
• Michelle Young, MSN, APN-BC, Adult Nurse
Practitioner in the Cardiovascular … Implementation of a Hybrid Cardiac Rehabilitation Program: AN
EXPANDING OPPORTUNITY FOR OPTIMIZING CARDIOVASCULAR … CARE
Cardiac Rehabilitation in Older Adults
Cardiac Rehabilitation in Frail Older Adults With Cardiovascular
-
meps.ahrq.gov/data_files/publications/st313/stat313.pdf
February 01, 2011 - expense among
adults for prescription
drugs were: metabolic
agents, central nervous
system agents,
cardiovascular … was more than three
times the average expense
of the therapeutic class
with the lowest average
(cardiovascular … The therapeutic class cardiovascular agents
includes calcium channel blockers and diuretics; central … , 2008
22.5
15.1
12.3
8.48.7
0
10
20
30
40
Metabolic agents
Central nervous system agents
Cardiovascular … 33.8
46.0
41.4
17.7 17.1
0
10
20
30
40
50
Metabolic agents
Central nervous system agents
Cardiovascular